WE ARE EXCITED TO FORMALLY ANNOUNCE THAT.

The AiGuardian™ System represents a breakthrough in autonomous medical treatment, integrating real-time physiological monitoring, AI-powered emergency detection, secure cloud authorization, and needle-based precision drug delivery—all within a coordinated, wearable ecosystem.

At the heart of the system are four synergistic innovations:

• SafeWatch™: A discreet, wrist-worn wearable that continuously monitors vital signs such as heart rate, oxygen saturation, movement, and skin temperature. It acts as the frontline sentinel, transmitting encrypted health telemetry 24/7.

• AiGenie™: A system-on-chip (SoC) embedded within SafeWatch™, AiGenie™ utilizes a triple-layered emergency detection engine combining rule-based logic, neural network analysis, and user-specific anomaly modeling to detect overdose, anaphylaxis, or cardiac abnormalities in real time.

• AiGuard™: Operating in the cloud, AiGuard™ receives encrypted signals from SafeWatch™ and performs advanced verification using digital signatures, timestamp validation, and severity thresholds. If criteria are met, it issues a one-time-use token authorizing medication delivery, while simultaneously notifying caregivers and emergency responders.

• SurDose™: A body-worn, skin-adhered injection module that remains dormant until activated by AiGuard™’s secure signal. Upon authorization, it delivers a precise, retractable-needle dose of life-saving medication (opioid antagonist, epinephrine, or atropine) directly into subcutaneous tissue—no user action required.

"The AiGuardian™ System is not just a wearable—it's an autonomous intervention platform," 

The full AiGuardian™ platform is now patent-pending in Canada with multiple divisionals protecting its core components and subsystems.

SaferSolutions is actively seeking licensing partners and strategic investors to bring this disruptive technology to market. For more information or partnership inquiries, please contact us.

04/29/2025 -Last Updated